Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease
Mahadevan, U., Vermeire, S., Lasch, K., Abhyankar, B., Bhayat, F., Blake, A., Dubinsky, M.
Published in Alimentary pharmacology & therapeutics (01.04.2017)
Published in Alimentary pharmacology & therapeutics (01.04.2017)
Get full text
Journal Article
Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease—authors’ reply
Mahadevan, U., Vermeire, S., Lasch, K., Abhyankar, B., Bhayat, F., Blake, A., Dubinsky, M.
Published in Alimentary pharmacology & therapeutics (01.08.2018)
Published in Alimentary pharmacology & therapeutics (01.08.2018)
Get full text
Journal Article
Structured Assessment for Prospective Identification of Safety Signals in Electronic Medical Records: Evaluation in the Health Improvement Network
Cederholm, S., Hill, G., Asiimwe, A., Bate, A., Bhayat, F., Persson Brobert, G., Bergvall, T., Ansell, D., Star, K., Norén, G. N.
Published in Drug safety (01.01.2015)
Published in Drug safety (01.01.2015)
Get full text
Journal Article
NSAID use and risk of leukaemia: a population-based case-control study
Bhayat, F., Das-Gupta, E., Smith, C., Hubbard, R.
Published in Pharmacoepidemiology and drug safety (01.09.2009)
Published in Pharmacoepidemiology and drug safety (01.09.2009)
Get full text
Journal Article
P461 Post-marketing safety experience of vedolizumab in older patients with inflammatory bowel disease
Travis, S, Ungaro, R, Blake, A, Bhayat, F, Card, T
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
P051 Lower incidence of herpes zoster in vedolizumab-treated vs. tofacitinib-treated patients with ulcerative colitis
Caldera, F, Lasch, K, Lissoos, T, Cao, C, Bhayat, F
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
PTH-067 Incidence of pneumonia and other respiratory tract infections with vedolizumab treatment: clinical trial experience
Feagan, BG, Bhayat, F, Khalid, JM, Palo, W, Blake, A, Shetzline, M, Travis, SP
Published in Gut (01.07.2017)
Published in Gut (01.07.2017)
Get full text
Journal Article
P442 Incidence of pneumonia and other respiratory tract infections with vedolizumab treatment for inflammatory bowel disease: clinical trial experience
Feagan, B., Bhayat, F., Khalid, J.M., Palo, W., Blake, A., Shetzline, M., Travis, S.
Published in Journal of Crohn's and colitis (01.02.2017)
Published in Journal of Crohn's and colitis (01.02.2017)
Get full text
Journal Article
P647 Tuberculosis in patients treated with vedolizumab: clinical trial and post-marketing case series
Zerôncio, M., Blake, A., Rana-Khan, Q., Palo, W., Bhayat, F.
Published in Journal of Crohn's and colitis (01.02.2017)
Published in Journal of Crohn's and colitis (01.02.2017)
Get full text
Journal Article
DOP024 Vedolizumab clinical and post-marketing safety experience of opportunistic infections
Ng, S.C., Palo, W., Blake, A., Rana-Khan, Q., Bhayat, F.
Published in Journal of Crohn's and colitis (01.02.2017)
Published in Journal of Crohn's and colitis (01.02.2017)
Get full text
Journal Article